REPATHA (EVOLOCUMAB) FOUR-YEAR OPEN-LABEL FOLLOW-UP STUDY PUBLISHED IN JAMA CARDIOLOGY Long-Term Study Identified No New Safety Concerns | Amgen AB
JAMA Cardiology on LinkedIn: The AWARE Trial tested an augmented WACA in patients with paroxysmal AF. A…
JAMA Cardiology - In this 12-month, placebo-controlled RCT of 26 well-treated persons with HIV without known CVD, eplerenone was associated with a significant reduction in arterial inflammation. https://ja.ma/49R22db | Facebook
![MHIF Advances Understanding of Aortic Dissection Outcomes - Research Published Online in JAMA Cardiology | Minneapolis Heart Institute Foundation MHIF Advances Understanding of Aortic Dissection Outcomes - Research Published Online in JAMA Cardiology | Minneapolis Heart Institute Foundation](https://mplsheart.org/sites/default/files/styles/large/public/2022-09/biblioteca-universidad-simon-bolivar-jn.jpg?itok=7F6c9-pg)